Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2140303rdf:typepubmed:Citationlld:pubmed
pubmed-article:2140303lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2140303lifeskim:mentionsumls-concept:C0012155lld:lifeskim
pubmed-article:2140303lifeskim:mentionsumls-concept:C0022709lld:lifeskim
pubmed-article:2140303lifeskim:mentionsumls-concept:C0037494lld:lifeskim
pubmed-article:2140303lifeskim:mentionsumls-concept:C0038432lld:lifeskim
pubmed-article:2140303lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2140303lifeskim:mentionsumls-concept:C1524081lld:lifeskim
pubmed-article:2140303lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:2140303pubmed:issue3lld:pubmed
pubmed-article:2140303pubmed:dateCreated1990-6-27lld:pubmed
pubmed-article:2140303pubmed:abstractText1. To dissociate the effects on the development of diabetic renal injury of angiotensin converting enzyme (ACE) inhibition per se, and a reduction in systemic blood pressure, we have studied the effects of chronic ramapril treatment in streptozotocin diabetic spontaneously hypertensive rats, with modulation of the hypotensive effect by a high salt diet. 2. Three weeks following uninephrectomy and induction of diabetes with streptozotocin, spontaneously hypertensive rats were allocated to three treatment groups. Groups 1 and 2 received 1% sodium chloride and Group 3 water as drinking solution. Groups 2 and 3 received 0.4 mg/kg per day ramapril in drinking solution over the subsequent 2 month study period. 3. Sodium chloride drinking solution (1%) completely prevented any hypotensive effect of ramapril. Blood pressure was reduced in Group 3 rats over the entire period of study, when compared with Group 2 rats (P less than 0.001). 4. Urinary protein excretion progressively increased in Group 1 and 2 rats, and was significantly reduced (P less than 0.001) in Group 3. After 2 months treatment, urinary protein (expressed as mean and s.e.m.) was 160 +/- 30 mg/day in Group 1, 240 +/- 50 mg/day in Group 2, and 60 +/- 11 mg/day in Group 3. 5. Angiotensin converting enzyme inhibition per se was not associated with a reduced protein excretion in diabetic nephropathy, requiring concomitant control of systemic blood pressure to become renoprotective.lld:pubmed
pubmed-article:2140303pubmed:languageenglld:pubmed
pubmed-article:2140303pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2140303pubmed:citationSubsetIMlld:pubmed
pubmed-article:2140303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2140303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2140303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2140303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2140303pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2140303pubmed:statusMEDLINElld:pubmed
pubmed-article:2140303pubmed:monthMarlld:pubmed
pubmed-article:2140303pubmed:issn0305-1870lld:pubmed
pubmed-article:2140303pubmed:authorpubmed-author:JohnstonC ICIlld:pubmed
pubmed-article:2140303pubmed:authorpubmed-author:JacksonBBlld:pubmed
pubmed-article:2140303pubmed:authorpubmed-author:PaxtonDDlld:pubmed
pubmed-article:2140303pubmed:authorpubmed-author:FabrisBBlld:pubmed
pubmed-article:2140303pubmed:authorpubmed-author:FranzeLLlld:pubmed
pubmed-article:2140303pubmed:issnTypePrintlld:pubmed
pubmed-article:2140303pubmed:volume17lld:pubmed
pubmed-article:2140303pubmed:ownerNLMlld:pubmed
pubmed-article:2140303pubmed:authorsCompleteYlld:pubmed
pubmed-article:2140303pubmed:pagination229-34lld:pubmed
pubmed-article:2140303pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:meshHeadingpubmed-meshheading:2140303-...lld:pubmed
pubmed-article:2140303pubmed:year1990lld:pubmed
pubmed-article:2140303pubmed:articleTitleHigh salt diet ameliorates effects of angiotensin converting enzyme inhibition in spontaneously hypertensive streptozotocin diabetic rats.lld:pubmed
pubmed-article:2140303pubmed:affiliationUniversity of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.lld:pubmed
pubmed-article:2140303pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2140303pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed